Find open access papers.Try setting your institution or searching for full access only papers.
  1. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.

    Journal of the American Academy of Dermatology 54(1):61 (2006) PMID 16384756

    Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided i...
  2. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

    Journal of the American Academy of Dermatology 54(1):61 (2006)

    Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provi...
  3. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.

    Journal of the American Academy of Dermatology 54(1):61 (2006) PMID 16384756

    Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided i...
  4. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.

    Archives of Dermatology 140(1):41 (2004) PMID 14732659

    To determine the safety and efficacy of photodynamic therapy (PDT) using 20% wt/vol aminolevulinic acid hydrochloride (hereinafter "ALA") and visible blue light for the treatment of multiple actinic keratoses of the face and scalp. Randomized, placebo-controlled, uneven parallel-group study. Pat...
  5. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.

    Archives of Dermatology 140(1):41 (2004) PMID 14732659

    To determine the safety and efficacy of photodynamic therapy (PDT) using 20% wt/vol aminolevulinic acid hydrochloride (hereinafter "ALA") and visible blue light for the treatment of multiple actinic keratoses of the face and scalp. Randomized, placebo-controlled, uneven parallel-group study. Pat...